デフォルト表紙
市場調査レポート
商品コード
1758898

心房細動手術の世界市場

Atrial Fibrillation Surgery


出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
心房細動手術の世界市場
出版日: 2025年06月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心房細動手術の世界市場は2030年までに53億米ドルに達する

2024年に23億米ドルと推定される心房細動手術の世界市場は、2024~2030年の分析期間においてCAGR 14.8%で成長し、2030年には53億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるカテーテルアブレーションは、CAGR 16.7%を記録し、分析期間終了時には37億米ドルに達すると予測されます。外科的アブレーション分野の成長率は、分析期間のCAGRで11.1%と推定されます。

米国市場は6億3,550万米ドルと推定、中国はCAGR20.0%で成長予測

米国の心房細動手術市場は、2024年に6億3,550万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは20.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ10.7%と13.4%と予測されています。欧州では、ドイツがCAGR 11.8%で成長すると予測されています。

世界の心房細動手術市場- 主要動向と促進要因まとめ

心房細動治療において外科的治療がますます重要になってきているのはなぜか?

一般的な不整脈の一種である心房細動(AF)は、脳卒中、心不全、心血管疾患全般との関連から、健康上の負担が増大しています。抗凝固薬や抗不整脈薬を含む内科的治療が引き続き治療において重要な役割を果たしている一方で、特に持続性または難治性の心房細動患者に対しては、外科的治療が長期的なリズムコントロールの中心となってきています。このような変化は、薬物療法の限界に起因しており、薬物療法には副作用、不十分な症状コントロール、時間の経過に伴う効果の減弱といった問題がしばしばあります。高齢化や高血圧、肥満、糖尿病などの病態の蔓延により、世界的に心房細動の発生率が上昇する中、より確実で持続可能な解決法として、外科的治療が注目されています。外科的手技の有効性を支持する臨床的エビデンスが増加し、特に再発率の減少やQOLの改善において、その魅力が高まっています。これと並行して、術中のマッピング、画像診断、アブレーションツールの進歩により、手術成績は著しく向上しています。特に、内科的治療で十分な効果が得られない場合に、より早い時期に手術を受ける患者が増えています。人口動態の変化、手技の安全性の向上、そして長期的な有効性が相まって、心房細動手術は単に最後の手段としてではなく、包括的なリズム管理戦略の中核をなすものとして位置づけられています。

技術的ブレークスルーは現代の心房細動手術をどのように形成しているか?

手術手技と技術の進化は、心房細動手術の展望を再定義する上で大きな役割を果たしてきました。歴史的には、Cox-Maze手術のような手技は非常に効果的であると考えられていたが、侵襲が大きく、開心術が必要であったため、その効果は限定的でした。今日、この分野では、より精度の高い、より患者リスクの低い手術とカテーテルを用いたアプローチを融合させた低侵襲・ハイブリッド治療へとパラダイムシフトが起こっています。高周波、冷凍アブレーション、さらに最近では高密度焦点式超音波などのエネルギーベースのアブレーション治療法の採用により、外科医はより高い精度で経皮的病変を形成し、手技時間を短縮できるようになりました。これらの治療法はリアルタイムの電気生理学的マッピングと3D可視化システムによってサポートされており、手術中、包括的なガイダンスを提供しています。さらに、ロボット支援手術の技術革新は、器用さと可視性を向上させ、小さな切開で複雑な操作を可能にし、回復時間の短縮につながっています。心外膜の外科的アブレーションと心内膜のカテーテルアブレーションを組み合わせたハイブリッド手術は、持続性心房細動や長期の持続性心房細動症例に特に有効であることが証明されつつあります。これらの手技は、カテーテルだけではアクセスできない領域に対応する病変セットを可能にします。さらに、人工知能と機械学習の統合は、個々の解剖学的・電気的プロファイルに合わせた最適なアブレーション戦略の同定を支援することで、手術計画に影響を与え始めています。これらの進歩により、外科手術の選択肢の範囲と安全性が大幅に拡大し、リズム矯正の長期的な解決策を求める臨床医と患者の双方にとって魅力的なものとなっています。

心房細動に対する外科的処置の需要はどのような外的要因によって支えられているのか?

心房細動の外科的治療に対する需要は、医療技術革新だけでなく、より広範な制度的・社会的要因によっても形成されています。重要な影響のひとつは、プロアクティブでアウトカム主導の治療へとヘルスケアパラダイムが変化していることです。多くの地域で、ヘルスケアシステムは長期入院率や再発介入を減少させる手技にインセンティブを与えており、適切に選択された患者にとって心房細動手術は費用対効果の高い選択肢となっています。さらに、特に新興国では、公立・私立病院を問わず外科手術が受けられるようになったことで、以前は地域や費用の制約によって制限されていた患者の治療へのアクセスが改善されています。循環器学会や患者擁護団体による啓発キャンペーンも、早期外科的介入の利点について一般市民や紹介医を教育する上で重要な役割を果たしています。医学的トレーニングプログラムも進化しており、より多くの心臓外科医が高度なアブレーション技術や低侵襲戦略のトレーニングを受けており、手技の利用可能性に関する以前の制限を克服するのに役立っています。外科的心房細動治療に対する保険適用も徐々に拡大しつつあり、特に実データが長期にわたる費用対効果を証明しています。もう1つの重要な要因は、患者主導の嗜好の変化です。多くの患者は現在、薬物依存を減らし、生活の質を向上させる長期的で非薬物療法的な解決策を求めています。これと並行して、ウェアラブルデバイスや遠隔モニタリングの普及により、無症候性または間欠的な心房細動の早期発見が可能になり、外科的介入の候補者層が広がっています。これらの外的要因が相まって、心房細動手術市場の手術件数と技術革新への投資は着実に増加しています。

心房細動手術市場の成長を促進する主な要因は何か?

心房細動手術市場の成長は、人口統計学的、技術的、臨床的、制度的発展に根ざしたいくつかの重要な要因によってもたらされます。第一に、世界人口の高齢化が大きく寄与しています。心房細動の有病率は年齢とともに著しく増加するため、高度なリズム制御介入を必要とする患者数が増加します。さらに、高血圧、冠動脈疾患、睡眠時無呼吸症候群などの併存疾患が急増しており、これらは心房細動の発症や進行と密接な関係があります。このような要因により、心房細動の治療は複雑化し、手術のようなより確実な治療法の必要性が高まっています。技術的には、リアルタイムのマッピングシステムとエネルギーベースのアブレーションツールに支えられた低侵襲技術の洗練によって、手術はより安全で、よりアクセスしやすく、より効果的なものとなっています。特に、両心房面に対応するハイブリッド・アプローチによる手術の長期的な成功に対する臨床医の信頼は、治療センター全体でより広範な採用につながっています。ヘルスケア提供の観点からは、診療報酬政策の改善と外科的介入の費用対効果に対する認識の高まりが、これらの手技を患者と医療提供者の双方にとってより経済的に実行可能なものにしています。さらに、病院は増加する手術需要に対応するため、専門の電気生理学的ユニットや手術インフラへの投資を進めています。最後に、患者の期待も変化しています。患者はますます情報に精通し、積極的に行動するようになり、長期的な薬物療法への依存を減らし、持続的な結果をもたらす選択肢を求めるようになっています。これらの要因が相まって、心房細動手術市場は、臨床上の必要性と進化するヘルスケア・エコシステムの両方に支えられながら、持続的かつ力強い成長を遂げるダイナミックな環境が整いつつあります。

セグメント

製品(カテーテルアブレーション、外科的アブレーション)

調査対象企業の例(全42件)

  • Abbott Laboratories
  • AtriCure Inc.
  • BIOTRONIK SE & Co. KG
  • Biosense Webster Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • CardioFocus Inc.
  • Endoscopic Technologies Inc.
  • Johnson & Johnson
  • Kardium Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Ncontact Inc.
  • OSYPKA AG
  • Sanofi-Aventis
  • Siemens Healthineers AG

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入(完成品とOEM)に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価(COGS)の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36223

Global Atrial Fibrillation Surgery Market to Reach US$5.3 Billion by 2030

The global market for Atrial Fibrillation Surgery estimated at US$2.3 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. Catheter Ablation, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Surgical Ablation segment is estimated at 11.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$635.5 Million While China is Forecast to Grow at 20.0% CAGR

The Atrial Fibrillation Surgery market in the U.S. is estimated at US$635.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 20.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.7% and 13.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.8% CAGR.

Global Atrial Fibrillation Surgery Market - Key Trends & Drivers Summarized

Why Is Surgical Intervention Becoming Increasingly Central in Atrial Fibrillation Management?

Atrial fibrillation (AF), a common type of cardiac arrhythmia, has become a growing health burden due to its association with stroke, heart failure, and overall cardiovascular morbidity. While medical management, including anticoagulants and antiarrhythmic drugs, continues to play an important role in treatment, surgical intervention is becoming increasingly central to long-term rhythm control, particularly for patients with persistent or refractory AF. This shift stems from the limitations of pharmacological therapies, which often present issues related to side effects, inadequate symptom control, or diminishing efficacy over time. As the global incidence of AF rises-fueled by an aging population and the prevalence of conditions such as hypertension, obesity, and diabetes-clinicians are turning to surgical procedures as a more definitive and sustainable solution. The growing body of clinical evidence supporting the efficacy of surgical techniques, especially in reducing recurrence rates and improving quality of life, has strengthened their appeal. In parallel, advancements in intraoperative mapping, imaging, and ablation tools have significantly improved surgical outcomes. Patients are increasingly being referred for surgery earlier in their disease course, especially when medical therapy fails to offer adequate relief. The combination of demographic shifts, improved procedural safety, and long-term efficacy is positioning AF surgery not merely as a last resort, but as a core component of a comprehensive rhythm management strategy.

How Are Technological Breakthroughs Shaping the Modern AF Surgery Landscape?

The evolution of surgical techniques and technologies has played a transformative role in redefining the atrial fibrillation surgery landscape. Historically, procedures like the Cox-Maze surgery were considered highly effective but were limited by their invasiveness and the need for open-heart access. Today, the field has seen a paradigm shift toward minimally invasive and hybrid procedures that blend surgical and catheter-based approaches for better precision and lower patient risk. The adoption of energy-based ablation modalities-such as radiofrequency, cryoablation, and more recently, high-intensity focused ultrasound-has allowed surgeons to create transmural lesions with greater accuracy and reduced procedural time. These modalities are supported by real-time electrophysiological mapping and 3D visualization systems, which provide comprehensive guidance throughout the operation. Furthermore, innovations in robotic-assisted surgery have enhanced dexterity and visualization, enabling complex maneuvers through small incisions and leading to faster recovery times. Hybrid procedures that combine epicardial surgical ablation with endocardial catheter ablation are proving especially effective for persistent and long-standing persistent AF cases. These techniques allow for lesion sets that address areas inaccessible by catheter alone. Additionally, the integration of artificial intelligence and machine learning is starting to influence surgical planning by helping identify optimal ablation strategies tailored to individual anatomical and electrical profiles. These advancements have significantly expanded the scope and safety of surgical options, making them more appealing to both clinicians and patients seeking a long-term solution for rhythm correction.

What External Dynamics Are Steering the Demand for AF Surgical Procedures?

The demand for atrial fibrillation surgical interventions is shaped not only by medical innovation but also by broader systemic and societal factors. One significant influence is the shifting healthcare paradigm toward proactive and outcome-driven interventions. In many regions, healthcare systems are incentivizing procedures that reduce long-term hospitalization rates and recurrent interventions, which positions AF surgery as a cost-effective option for appropriately selected patients. Moreover, the increased availability of surgical services in both public and private hospitals, especially in emerging economies, has improved access to care for patients previously limited by geography or cost constraints. Awareness campaigns by cardiology societies and patient advocacy groups have also played a crucial role in educating the public and referring physicians about the benefits of early surgical intervention. Medical training programs are evolving as well, with more cardiac surgeons being trained in advanced ablation techniques and minimally invasive strategies, helping to overcome earlier limitations related to procedural availability. Insurance coverage for surgical AF treatments is gradually expanding, especially as real-world data demonstrate their cost-effectiveness over time. Another significant factor is the patient-driven shift in preferences-many individuals now seek long-term, non-pharmacological solutions that reduce medication dependency and improve quality of life. In parallel, the increasing use of wearable devices and remote monitoring has led to earlier detection of asymptomatic or intermittent AF, which broadens the candidate pool for surgical intervention. Collectively, these external forces are driving a steady rise in both procedural volumes and innovation investment within the AF surgical market.

What Are the Primary Drivers Fueling Growth in the Atrial Fibrillation Surgery Market?

The growth in the atrial fibrillation surgery market is driven by several key factors rooted in demographic, technological, clinical, and institutional developments. First, the aging global population is a major contributor, as AF prevalence increases significantly with age, creating a larger pool of patients requiring advanced rhythm control interventions. In addition, there is an upsurge in co-morbid conditions such as hypertension, coronary artery disease, and sleep apnea, which are closely linked to the onset and progression of atrial fibrillation. These factors increase the complexity of disease management and elevate the demand for more definitive treatment options such as surgery. Technologically, the refinement of minimally invasive techniques, supported by real-time mapping systems and energy-based ablation tools, has made surgery safer, more accessible, and more effective. Clinician confidence in the long-term success of procedures-particularly hybrid approaches that address both atrial surfaces-has led to broader adoption across treatment centers. From a healthcare delivery standpoint, improved reimbursement policies and growing recognition of the cost-benefit profile of surgical interventions are making these procedures more financially viable for both patients and providers. Additionally, hospitals are investing in specialized electrophysiology units and surgical infrastructure to meet rising procedural demand. Finally, patient expectations are changing; individuals are increasingly informed and proactive, seeking out options that offer lasting results with reduced reliance on long-term medications. These combined drivers are creating a dynamic environment where the atrial fibrillation surgery market is poised for sustained and robust growth, supported by both clinical necessity and evolving healthcare ecosystems.

SCOPE OF STUDY:

The report analyzes the Atrial Fibrillation Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Catheter Ablation, Surgical Ablation)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • AtriCure Inc.
  • BIOTRONIK SE & Co. KG
  • Biosense Webster Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • CardioFocus Inc.
  • Endoscopic Technologies Inc.
  • Johnson & Johnson
  • Kardium Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Ncontact Inc.
  • OSYPKA AG
  • Sanofi-Aventis
  • Siemens Healthineers AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Atrial Fibrillation Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Atrial Fibrillation Spurs Demand for Surgical Interventions
    • Increased Focus on Minimally Invasive Procedures Drives Adoption of Advanced Surgical Techniques
    • Boom in Aging Populations and Comorbidities Expands the Addressable Market for Atrial Fibrillation Surgery
    • Growing Emphasis on Long-term Rhythm Control Throws the Spotlight on Surgical Ablation Options
    • Advances in Energy Sources and Mapping Technologies Propel Innovation in Surgical Outcomes
    • Demand for Hybrid Procedures Combining Catheter and Surgical Approaches Strengthens Treatment Adoption
    • Here's How Early Diagnosis and Risk Stratification Accelerate Surgical Referrals
    • Wider Integration of Robotic-assisted Surgery Generates Precision and Reduced Recovery Times
    • Rising Surgical Volumes in High-risk Patient Groups Sustain Market Growth
    • Expansion of Electrophysiology Programs and Specialized Cardiac Centers Unlocks New Access Points
    • Growing Evidence Supporting Surgical Efficacy Fuels Clinical Guidelines and Physician Confidence
    • Increased Focus on Post-operative Monitoring and Recurrence Prevention Shapes Adjunct Therapy Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Atrial Fibrillation Surgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Atrial Fibrillation Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Catheter Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Catheter Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Catheter Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Surgical Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Surgical Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Surgical Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • JAPAN
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • CHINA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: China 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • EUROPE
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Atrial Fibrillation Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • FRANCE
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: France 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • GERMANY
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Atrial Fibrillation Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • INDIA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: India 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Atrial Fibrillation Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Atrial Fibrillation Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • AFRICA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030

IV. COMPETITION